Cresud SA (CRESY) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2026, filed Oct 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRESY SEC filings page.
Cresud SA (CRESY) reported $930.1M in revenue for fiscal year 2026, up 21.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Cresud SA's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cresud SA's revenue surged 21.5% year-over-year to $930.1M, reflecting rapid business expansion. This strong growth earns a score of 62/100.
Cresud SA has a moderate D/E ratio of 0.46. This balance of debt and equity financing earns a leverage score of 63/100.
Cresud SA's current ratio of 1.47 indicates adequate short-term liquidity, earning a score of 41/100. The company can meet its near-term obligations, though with limited headroom.
While Cresud SA generated $42.4M in operating cash flow, capex of $36.7M consumed most of it, leaving $5.7M in free cash flow. This results in a low score of 39/100, reflecting heavy capital investment rather than weak cash generation.
Cresud SA's ROE of 5.6% shows moderate profitability relative to equity, earning a score of 52/100. This is up from 4.3% the prior year.
Cresud SA passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Cresud SA generates $0.36 in operating cash flow ($42.4M OCF vs $119.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Cresud SA generated $930.1M in revenue in fiscal year 2026. This represents an increase of 21.5% from the prior year.
Cresud SA reported $119.5M in net income in fiscal year 2026. This represents an increase of 48.4% from the prior year.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Cash & Balance Sheet
Cresud SA generated $5.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 93.5% from the prior year.
Cresud SA held $191.8M in cash against $982.9M in long-term debt as of fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
Cresud SA's gross margin was 39.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 1.3 percentage points from the prior year.
Cresud SA's net profit margin was 12.8% in fiscal year 2026, showing the share of revenue converted to profit. This is up 2.3 percentage points from the prior year.
Cresud SA's ROE was 5.6% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the prior year.
Not reported for fiscal year 2026.
Capital Allocation
Cresud SA invested $36.7M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 4.1% from the prior year.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
CRESY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $930.1M+21.5% | $765.6M-1.9% | $780.2M+5.2% | $741.8M-3.1% | $765.5M+72.8% | $443.0M-74.3% | $1.7B-11.0% | $1.9B+39.3% | $1.4B |
| Cost of Revenue | $579.6M+21.3% | $478.0M+0.6% | $475.0Mn/m | -$449.2M-180.6% | $557.3M+57.7% | $353.4M-70.4% | $1.2B-4.2% | $1.2B+41.1% | $883.1M |
| Gross Profit | $362.9M+17.7% | $308.2M-3.6% | $319.8M+15.2% | $277.7M-18.1% | $339.1M+44.6% | $234.6M-59.5% | $579.5M-20.3% | $727.4M+31.2% | $554.2M |
| Operating Income | N/A | N/A | N/A | N/A | $345.2M+233.0% | $103.7M-83.5% | $626.4Mn/m | -$229.7M-121.5% | $1.1B |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | $859.9Mn/m | -$51.6M-104.3% | $1.2B |
| Interest Expense | $120.7M+77.3% | $68.1M-15.5% | $80.6M-12.7% | $92.4M-25.7% | $124.4M-16.2% | $148.4M-57.1% | $346.2M-13.1% | $398.4M+35.4% | $294.3M |
| Income Tax | $741K+68.2% | $441K+66.0% | $265K | N/A | N/A | N/A | $115.2M+168.9% | $42.9M+416.1% | $8.3M |
| Net Income | $119.5M+48.4% | $80.5M-6.4% | $86.1M-71.7% | $304.6M-39.5% | $503.1Mn/m | -$256.0M-558.3% | $55.8Mn/m | -$439.1M-328.5% | $192.2M |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | N/A | -$0.11n/m | -$0.90-332.0% | $0.39 |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | -$0.11n/m | -$0.90-341.3% | $0.37 |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 516 |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses.
CRESY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.9B+14.6% | $4.3B+11.9% | $3.8B-8.6% | $4.2B-1.4% | $4.2B+19.3% | $3.5B-63.7% | $9.8B-17.9% | $11.9B-5.6% | $12.6B |
| Current Assets | $1.2B+17.8% | $1.0B+34.8% | $774.8M-7.5% | $837.4M-7.2% | $902.4M+23.4% | $731.0M-77.7% | $3.3B-8.4% | $3.6B-1.8% | $3.7B |
| Cash & Equivalents | $191.8M-8.7% | $210.1M+67.1% | $125.7M-17.1% | $151.7M-45.6% | $278.8M-3.0% | $287.6M-80.0% | $1.4B-2.0% | $1.5B+6.2% | $1.4B |
| Inventory | $168.7M+13.6% | $148.6M+16.5% | $127.5M+16.0% | $109.9M+2.6% | $107.2M-4.0% | $111.6M-13.4% | $128.9M+22.9% | $104.9M+26.7% | $82.8M |
| Accounts Receivable | $408.5M+10.2% | $370.9M+29.2% | $287.0M-5.3% | $303.2M+14.0% | $266.1M+1701.3% | $14.8M-97.6% | $621.4M-1.4% | $630.1M+2.7% | $613.3M |
| Goodwill | $27.9M+17.1% | $23.9M-70.0% | $79.5M+104.7% | $38.8M+13.6% | $34.2M+9.5% | $31.2M-92.2% | $400.7M-6.0% | $426.3M-3.2% | $440.6M |
| Total Liabilities | $2.8B+14.5% | $2.4B+15.0% | $2.1B-8.3% | $2.3B-11.3% | $2.6B+5.7% | $2.4B-69.6% | $8.0B-18.2% | $9.8B-1.1% | $9.9B |
| Current Liabilities | $839.6M+0.1% | $839.0M+16.3% | $721.3M-5.1% | $759.8M-35.5% | $1.2B+60.2% | $735.7M-70.1% | $2.5B+17.1% | $2.1B+3.2% | $2.0B |
| Non-Current Liabilities | $1.9B+22.3% | $1.6B+14.3% | $1.4B-10.0% | $1.5B+9.2% | $1.4B-17.9% | $1.7B-69.5% | $5.6B-27.8% | $7.7B-2.2% | $7.9B |
| Long-Term Debt | $982.9M+45.4% | $676.1M+29.6% | $521.6M-16.0% | $620.8M+68.4% | $368.7M-51.8% | $765.0M-83.2% | $4.6B-30.1% | $6.5B-2.5% | $6.7B |
| Total Equity | $2.1B+14.7% | $1.9B+8.1% | $1.7B-8.9% | $1.9B+14.0% | $1.7B+49.3% | $1.1B-36.3% | $1.7B-16.7% | $2.1B-22.4% | $2.7B |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | $12.1M | N/A | N/A | $745.7M |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
CRESY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $42.4M-66.5% | $126.7M+68.4% | $75.3M-46.3% | $140.2M-19.5% | $174.2M | N/A | $507.9M+21.3% | $418.6M-14.7% | $490.9M |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | N/A | N/A | $233.5M+31.1% | $178.1M+32.8% | $134.1M |
| Capital Expenditures | $36.7M-4.1% | $38.3M-55.5% | $86.0M | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $5.7M-93.5% | $88.4Mn/m | -$10.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$206.7Mn/m | -$67.5M-166.5% | $101.5M+74.7% | $58.1M-43.6% | $103.0M | N/A | $573.0M+231.4% | $172.9Mn/m | -$426.7M |
| Financing Cash Flow | $127.9M+77.2% | $72.2Mn/m | -$228.7Mn/m | -$353.5Mn/m | -$295.6M | N/A | -$1.0Bn/m | -$421.7Mn/m | -$81.9M |
| Dividends Paid | $71.3M-2.6% | $73.2M-46.0% | $135.5M | N/A | N/A | N/A | N/A | $10.9M-67.4% | $33.5M |
| Share Buybacks | N/A | N/A | N/A | $26.8M+2137.5% | $1.2M | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation.
CRESY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.0%-1.3pp | 40.3%-0.7pp | 41.0%+3.5pp | 37.4%-6.9pp | 44.3%-8.6pp | 52.9%+19.3pp | 33.6%-3.9pp | 37.6%-2.3pp | 39.9% |
| Operating Margin | N/A | N/A | N/A | N/A | 45.1%+21.7pp | 23.4%-12.9pp | 36.4%+48.2pp | -11.9%-88.7pp | 76.9% |
| Net Margin | 12.8%+2.3pp | 10.5%-0.5pp | 11.0%-30.0pp | 41.1%-24.7pp | 65.7%+123.5pp | -57.8%-61.0pp | 3.2%+25.9pp | -22.7%-36.5pp | 13.8% |
| Return on Equity | 5.6%+1.3pp | 4.3%-0.7pp | 5.0%-11.2pp | 16.2%-14.3pp | 30.5%+53.6pp | -23.1%-26.4pp | 3.2%+24.3pp | -21.1%-28.2pp | 7.2% |
| Return on Assets | 2.5%+0.6pp | 1.9%-0.4pp | 2.3%-5.1pp | 7.3%-4.6pp | 11.9%+19.1pp | -7.2%-7.8pp | 0.6%+4.3pp | -3.7%-5.2pp | 1.5% |
| Current Ratio | 1.47+0.2x | 1.24+0.2x | 1.070.0x | 1.10+0.3x | 0.77-0.2x | 0.99-0.3x | 1.34-0.4x | 1.71-0.1x | 1.80 |
| Debt-to-Equity | 0.46+0.1x | 0.36+0.1x | 0.300.0x | 0.33+0.1x | 0.22-0.5x | 0.69-1.9x | 2.62-0.5x | 3.12+0.6x | 2.49 |
| Liabilities-to-Equity | 1.300.0x | 1.30+0.1x | 1.220.0x | 1.21-0.3x | 1.56-0.6x | 2.20-2.4x | 4.62-0.1x | 4.71+1.0x | 3.70 |
| Asset Turnover | 0.190.0x | 0.180.0x | 0.200.0x | 0.180.0x | 0.18+0.1x | 0.13-0.1x | 0.180.0x | 0.16+0.1x | 0.11 |
| FCF Margin | 0.6%-10.9pp | 11.6%+12.9pp | -1.4% | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Cresud SA CRESY | FY2026 | $930.1M | $119.5M | 12.8% | $662.4M | 56/100 |
| Matthews International Corp MATW | FY2025 | $1.5B | -$24.5M | -1.6% | $634.3M | 26/100 |
| Compass Diversified CODI | FY2025 | $1.9B | -$226.4M | -12.1% | $926.2M | 31/100 |
| Falcon's Beyond Global, Inc. FBYD | FY2025 | $14.9M | $2.8M | 19.1% | $937.6M | 16/100 |
| Tejon Ranch Co. TRC | FY2025 | $49.6M | $75K | 0.1% | $439.9M | 42/100 |
| Boston Omaha Corporation BOC | FY2025 | $114.4M | -$12.4M | -10.9% | $422.4M | 59/100 |
Where Cresud SA Ranks
Frequently Asked Questions
Cresud SA (CRESY) reported $930.1M in total revenue for fiscal year 2026. This represents a 21.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Cresud SA (CRESY) revenue grew by 21.5% year-over-year, from $765.6M to $930.1M in fiscal year 2026.
Yes, Cresud SA (CRESY) reported a net income of $119.5M in fiscal year 2026, with a net profit margin of 12.8%.
As of fiscal year 2026, Cresud SA (CRESY) had $191.8M in cash and equivalents against $982.9M in long-term debt.
Cresud SA (CRESY) had a gross margin of 39.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
Cresud SA (CRESY) had a net profit margin of 12.8% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Cresud SA (CRESY) has a return on equity of 5.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Cresud SA (CRESY) generated $5.7M in free cash flow during fiscal year 2026. This represents a -93.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Cresud SA (CRESY) generated $42.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
Cresud SA (CRESY) had $4.9B in total assets as of fiscal year 2026, including both current and long-term assets.
Cresud SA (CRESY) invested $36.7M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
Cresud SA (CRESY) had a current ratio of 1.47 as of fiscal year 2026, which is considered adequate.
Cresud SA (CRESY) had a debt-to-equity ratio of 0.46 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Cresud SA (CRESY) had a liabilities-to-equity ratio of 1.30 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Cresud SA (CRESY) had a return on assets of 2.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Cresud SA (CRESY) trades at 5.5x earnings, its market capitalization divided by $119.5M net income, FY2026. The market capitalization is $662.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Cresud SA (CRESY) trades at 0.7x sales, its market capitalization divided by $930.1M revenue, FY2026. The market capitalization is $662.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Cresud SA (CRESY) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Cresud SA (CRESY) has an earnings quality ratio of 0.36x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Cresud SA (CRESY) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.